Novo Ventures and HBM Partners have led a CHF 100m series-C funding round for Switzerland-based Numab Therapeutics, a multi-specific antibodies developer.
Fund has made four platform investments and backs European digital and technology-based companies
Toni Gillespie joins as chief of talent, while Elisabetta Ricci joins as chief of staff
GP backed the business – then called Ryds Bilglas – via Nordic Capital VIII in 2018
Auction of the Italian producer of natural flavours and ingredients is expected to launch in early 2022